AD MEDICAL LIMITED

Company Registration Number:
SC630065 (Scotland)

Unaudited micro entity accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

AD MEDICAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

AD MEDICAL LIMITED

Company Information

for the Period Ended 31 March 2025




Registered office: 5
South Charlotte Street
Edinburgh
GB-SCT
EH2 4AN
Company Registration Number: SC630065 (Scotland)

AD MEDICAL LIMITED

Balance sheet

As at 31 March 2025


2025
£

2024
£
Fixed Assets: 31,492 39,890
Current assets: 6,476 4,591
Creditors: amounts falling due within one year: ( 9,672 ) ( 12,745 )
Net current assets (liabilities): ( 3,196 ) ( 8,154 )
Total assets less current liabilities: 28,296 31,736
Creditors: amounts falling due after more than one year: ( 12,301 ) ( 12,301 )
Total net assets (liabilities): 15,995 19,435
Capital and reserves: 15,995 19,435

AD MEDICAL LIMITED

Balance sheet continued

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 8 December 2025
And Signed On Behalf Of The Board By:

Name: Amanullah Durrani
Status: Director

The notes form part of these financial statements

AD MEDICAL LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Employee Information

    Average number of employees: 1

AD MEDICAL LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Off balance sheet disclosure

    No